Paramyxoviridae expression system
A paramyxovirus and virus technology, applied in the field of vaccines, can solve problems such as loss of inserted genes
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0026] The present invention solves the problems inherent in the prior art and provides a significant advance over the state of the art.
[0027] The present invention demonstrates the exploration of CDV recombinants (ie, CDV vectors) encoding VP2 proteins of 2b or 2c CPV genotypes generated according to the examples provided herein by in vitro data. The viruses displayed good growth kinetics for production in Vero cells and reached peak titers at 6 days post infection in roller bottles. These recombinants displayed strong expression properties of the transgene (VP2), as determined by immunofluorescence and Western blot, which quantified these recombinants as dual CDV-CPV vaccine candidates. Additionally, the genetic stability of the viruses was tested in Vero cells for 20 cell passages. Both viruses remained completely genetically stable, indicating their ease of bioprocessing for vaccines.
[0028] The present invention further confirms through in vivo results that the CDV...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com